Mairal A, Langin D, Arner P, Hoffstedt J
Inserm, U586, Obesity Research Unit, Toulouse, France.
Diabetologia. 2006 Jul;49(7):1629-36. doi: 10.1007/s00125-006-0272-x. Epub 2006 May 10.
AIMS/HYPOTHESIS: The recent identification of murine adipose triglyceride lipase (ATGL, now known as patatin-like phospholipase domain containing 2 [PNPLA2]), gene product of Pnpla2, has questioned the unique role of hormone sensitive lipase (HSL, now known as LIPE), gene product of Lipe, in fat cell lipolysis. Here, we investigated human ATGL and HSL adipose tissue gene expression and in vitro lipase activity.
SUBJECTS, MATERIALS AND METHODS: Levels of mRNA in adipose tissue from healthy obese and non-obese subjects were measured and lipase activity and adipocyte lipolytic capacity determined. HSL and ATGL cDNAs were transfected into Cos-7 cells and the relative tri- and diglyceride hydrolase activities were measured.
Obesity was associated with a decreased subcutaneous and increased omental adipose tissue level of HSL mRNA. Subcutaneous HSL mRNA content was normalised upon weight reduction. In contrast, ATGL mRNA levels were unaffected by obesity and weight reduction. A high adipose tissue lipase activity was associated with increased maximal lipolysis and increased HSL, but not with ATGL mRNA levels. The in vitro triglyceride hydrolase activity of HSL was markedly higher than that of ATGL and contrary to HSL, ATGL was devoid of diglyceride hydrolase activity. The use of a selective HSL-inhibitor resulted in complete inhibition of HSL-mediated tri- and diglyceride hydrolase activity. The pH profile of human white adipose tissue triolein hydrolase activity was identical to that of HSL but differed from the ATGL profile.
CONCLUSIONS/INTERPRETATION: HSL, but not ATGL gene expression shows a regulation according to obesity status and is associated with increased adipose tissue lipase activity. Moreover, HSL has a higher capacity than ATGL to hydrolyse triglycerides in vitro.
目的/假设:最近对小鼠脂肪甘油三酯脂肪酶(ATGL,现称为含patatin样磷脂酶结构域2 [PNPLA2]),即Pnpla2的基因产物的鉴定,对激素敏感性脂肪酶(HSL,现称为LIPE),即Lipe的基因产物在脂肪细胞脂解中的独特作用提出了质疑。在此,我们研究了人ATGL和HSL在脂肪组织中的基因表达及体外脂肪酶活性。
受试者、材料与方法:测量健康肥胖和非肥胖受试者脂肪组织中的mRNA水平,并测定脂肪酶活性和脂肪细胞的脂解能力。将HSL和ATGL的cDNA转染到Cos-7细胞中,并测量相对甘油三酯和甘油二酯水解酶活性。
肥胖与皮下脂肪组织中HSL mRNA水平降低以及网膜脂肪组织中HSL mRNA水平升高有关。体重减轻后,皮下HSL mRNA含量恢复正常。相比之下,ATGL mRNA水平不受肥胖和体重减轻的影响。高脂肪组织脂肪酶活性与最大脂解增加和HSL升高有关,但与ATGL mRNA水平无关。HSL的体外甘油三酯水解酶活性明显高于ATGL,与HSL相反,ATGL缺乏甘油二酯水解酶活性。使用选择性HSL抑制剂可完全抑制HSL介导的甘油三酯和甘油二酯水解酶活性。人白色脂肪组织三油精水解酶活性的pH曲线与HSL相同,但与ATGL曲线不同。
结论/解读:HSL而非ATGL的基因表达根据肥胖状态呈现调节作用,且与脂肪组织脂肪酶活性增加有关。此外,在体外,HSL水解甘油三酯的能力高于ATGL。